Venetoclax, a cancer drug that inhibits BCL-2, reduced the intact SIV reservoir in macaques and may inform future HIV cure ...
The Boulder, CO, site is scheduled to become operational in the second half of 2027, following completion and qualification.
Results show that eliminating dendritic cells from the lymph nodes wiped out elevated levels of T cells in mice, and slowed cognitive decline.
Preclinical findings are the basis for an upcoming Phase II clinical trial evaluating psilocybin during chemotherapy in ...
Cell and gene therapies have entered a new phase of maturity. Scientific innovation continues at an unprecedented pace, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results